Abstract
Bone is a dynamic tissue that undergoes constant remodeling. Many intercellular messengers and cellular mechanisms regulate the rate and efficacy of bone remodeling, and disruption of this process can lead to such pathology as osteopenia and osteoporosis on one hand and osteopetrosis on the other. Results of recent studies indicate a central role for adenosine and its receptors in the control of bone and cartilage metabolism. Many studies using pharmacological and genetic approaches were performed in different laboratories in order to clarify the role, sometimes controversial, of adenosine in the skeletal system.
New bone formation during fractures or during development depends on differentiation and function of osteoblasts. Osteoblast differentiation and mineral deposition are processes stimulated by A2A and A2B adenosine receptors (A2AR and A2BR). A2AR and A2BR also block the differentiation and function of osteoclasts, the multinucleated giant cells that mediate bone resorption. In contrast the A1 adenosine receptor plays a prominent role in osteoclast where it stimulates their activity in bone resorption. Moreover it has been shown recently from our laboratory and previously from others that adenosine receptor, through A2AR, exerts an important role in cartilage protection during mechanical stress, inflammation, and osteoarthritis.
Access this chapter
Tax calculation will be finalised at checkout
Purchases are for personal use only
References
Anderson HC (2003) Matrix vesicles and calcification. Curr Rheumatol Rep 5(3):222–226
Ballarin M, Fredholm BB, Ambrosio S et al (1991) Extracellular levels of adenosine and its metabolites in the striatum of awake rats: inhibition of uptake and metabolism. Acta Physiol Scand 142(1):97–103
Bar-Yehuda S, Rath-Wolfson L, Del Valle L et al (2009) Induction of an antiinflammatory effect and prevention of cartilage damage in rat knee osteoarthritis by CF101 treatment. Arthritis Rheum 60(10):3061–3071
Benton HP, MacDonald MH, Tesch AM (2002) Effects of adenosine on bacterial lipopolysaccharide- and interleukin 1-induced nitric oxide release from equine articular chondrocytes. Am J Vet Res 63(2):204–210
Bitto A, Polito F, Irrera N, D'Ascola A et al (2011) Polydeoxyribonucleotide reduces cytokine production and the severity of collagen-induced arthritis by stimulation of adenosine A((2)A) receptor. Arthritis Rheum 63(11):3364–3371
Bradaschia-Correa V, Josephson AM, Egol AJ et al (2017) Ecto-5′-nucleotidase (CD73) regulates bone formation and remodeling during intramembranous bone repair in aging mice. Tissue Cell 49(5):545–551
Burnstock G (2016) An introduction to the roles of purinergic signalling in neurodegeneration, neuroprotection and neuroregeneration. Neuropharmacology 104:4–17
Burnstock G, Cocks T, Crowe R et al (1978) Purinergic innervation of the guinea-pig urinary bladder. Br J Pharmacol 63(1):125–138
Carroll SH, Wigner NA, Kulkarni N et al (2012) A2B adenosine receptor promotes mesenchymal stem cell differentiation to osteoblasts and bone formation in vivo. J Biol Chem 287(19):15718–15727
Cekic C, Linden J (2016) Purinergic regulation of the immune system. Nat Rev Immunol 16(3):177–192
Chan ES, Cronstein BN (2010) Methotrexate--how does it really work? Nat Rev Rheumatol 6(3):175–178
Corciulo C, Wilder T, Cronstein BN (2016) Adenosine A2B receptors play an important role in bone homeostasis. Purinergic Signal 12(3):537–547
Corciulo C, Lendhey M, Wilder T et al (2017) Endogenous adenosine maintains cartilage homeostasis and exogenous adenosine inhibits osteoarthritis progression. Nat Commun 8:15019
Cronstein BN, Naime D, Ostad E (1993) The antiinflammatory mechanism of methotrexate. Increased adenosine release at inflamed sites diminishes leukocyte accumulation in an in vivo model of inflammation. J Clin Invest 92(6):2675–2682
Di Virgilio F, Adinolfi E (2016) Extracellular purines, purinergic receptors and tumor growth. Oncogene 36:293–303
Emery NJ (2006) Cognitive ornithology: the evolution of avian intelligence. Philosophical transactions of the Royal Society of London. Series B: Biol Sci 361(1465):23–43
Fredholm BB (2007) Adenosine, an endogenous distress signal, modulates tissue damage and repair. Cell Death Differ 14(7):1315–1323
Fredholm BB, AP IJ, Jacobson KA et al (2001) International Union of Pharmacology. XXV. Nomenclature and classification of adenosine receptors. Pharmacol Rev 53(4):527–552
Fredholm BB, AP IJ, Jacobson KA et al (2011) International Union of Basic and Clinical Pharmacology. LXXXI. Nomenclature and classification of adenosine receptors--an update. Pharmacol Rev 63(1):1–34
Garg P, Mazur MM, Buck AC et al (2017) Prospective review of mesenchymal stem cells differentiation into osteoblasts. Orthop Surg 9(1):13–19
Hajjawi MO, Patel JJ, Corcelli M et al (2016) Lack of effect of adenosine on the function of rodent osteoblasts and osteoclasts in vitro. Purinergic Signal 12(2):247–258
He W, Cronstein BN (2012) Adenosine A1 receptor regulates osteoclast formation by altering TRAF6/TAK1 signaling. Purinergic Signal 8(2):327–337
He W, Mazumder A, Wilder T et al (2013a) Adenosine regulates bone metabolism via A1, A2A, and A2B receptors in bone marrow cells from normal humans and patients with multiple myeloma. FASEB J 27(9):3446–3454
He W, Wilder T, Cronstein BN (2013b) Rolofylline, an adenosine A1 receptor antagonist, inhibits osteoclast differentiation as an inverse agonist. Br J Pharmacol 170(6):1167–1176
Hemmatian H, Bakker AD, Klein-Nulend J et al (2017) Aging, osteocytes, and mechanotransduction. Curr Osteoporos Rep 15(5):401–411
Henriksen K, Bollerslev J, Everts V et al (2011) Osteoclast activity and subtypes as a function of physiology and pathology--implications for future treatments of osteoporosis. Endocr Rev 32(1):31–63
Hoebertz A, Arnett TR, Burnstock G (2003) Regulation of bone resorption and formation by purines and pyrimidines. Trends Pharmacol Sci 24(6):290–297
Honig M, Albert MH, Schulz A et al (2007) Patients with adenosine deaminase deficiency surviving after hematopoietic stem cell transplantation are at high risk of CNS complications. Blood 109(8):3595–3602
Ishack S, Mediero A, Wilder T et al (2015) Bone regeneration in critical bone defects using three-dimensionally printed beta-tricalcium phosphate/hydroxyapatite scaffolds is enhanced by coating scaffolds with either dipyridamole or BMP-2. J Biomed Mater Res B Appl Biomater 105(2):366–375
Ivashkiv LB, Zhao B, Park-Min KH et al (2011) Feedback inhibition of osteoclastogenesis during inflammation by IL-10, M-CSF receptor shedding, and induction of IRF8. Ann N Y Acad Sci 1237:88–94
Jacobson KA, Gao ZG (2006) Adenosine receptors as therapeutic targets. Nat Rev Drug Discov 5(3):247–264
Kang JH, Ko HM, Moon JS et al (2014) Osteoprotegerin expressed by osteoclasts: an autoregulator of osteoclastogenesis. J Dent Res 93(11):1116–1123
Kara FM, Chitu V, Sloane J et al (2010a) Adenosine A1 receptors (A1Rs) play a critical role in osteoclast formation and function. FASEB J 24(7):2325–2333
Kara FM, Doty SB, Boskey A et al (2010b) Adenosine A(1) receptors regulate bone resorption in mice: adenosine A(1) receptor blockade or deletion increases bone density and prevents ovariectomy-induced bone loss in adenosine A(1) receptor-knockout mice. Arthritis Rheum 62(2):534–541
Kim JH, Kim N (2016) Signaling pathways in osteoclast differentiation. Chonnam Med J 52(1):12–17
Kim N, Kadono Y, Takami M et al (2005) Osteoclast differentiation independent of the TRANCE-RANK-TRAF6 axis. J Exp Med 202(5):589–595
Klein-Nulend J, Bakker AD, Bacabac RG et al (2013) Mechanosensation and transduction in osteocytes. Bone 54(2):182–190
Manson D, Diamond L, Oudjhane K et al (2013) Characteristic scapular and rib changes on chest radiographs of children with ADA-deficiency SCIDS in the first year of life. Pediatr Radiol 43(5):589–592
Marie PJ, Hay E, Saidak Z (2014) Integrin and cadherin signaling in bone: role and potential therapeutic targets. Trends Endocrinol Metab 25(11):567–575
Mazzon E, Esposito E, Impellizzeri D et al (2011) CGS 21680, an agonist of the adenosine (A2A) receptor, reduces progression of murine type II collagen-induced arthritis. J Rheumatol 38(10):2119–2129
Mediero A, Frenkel SR, Wilder T et al (2012a) Adenosine A2A receptor activation prevents wear particle-induced osteolysis. Sci Transl Med 4(135):135ra165
Mediero A, Kara FM, Wilder T et al (2012b) Adenosine A(2A) receptor ligation inhibits osteoclast formation. Am J Pathol 180(2):775–786
Mediero A, Perez-Aso M, Wilder T et al (2015a) Brief report: methotrexate prevents wear particle-induced inflammatory osteolysis in mice via activation of adenosine A2A receptor. Arthritis Rheumatol 67(3):849–855
Mediero A, Wilder T, Perez-Aso M et al (2015b) Direct or indirect stimulation of adenosine A2A receptors enhances bone regeneration as well as bone morphogenetic protein-2. FASEB J 29(4):1577–1590
Mediero A, Wilder T, Reddy VS et al (2016) Ticagrelor regulates osteoblast and osteoclast function and promotes bone formation in vivo via an adenosine-dependent mechanism. FASEB J 30(11):3887–3900
Mistry D, Chambers MG, Mason RM (2006) The role of adenosine in chondrocyte death in murine osteoarthritis and in a murine chondrocyte cell line. Osteoarthr Cartil 14(5):486–495
Olsen BR, Reginato AM, Wang W (2000) Bone development. Annu Rev Cell Dev Biol 16:191–220
Orriss IR, Burnstock G, Arnett TR (2010) Purinergic signalling and bone remodelling. Curr Opin Pharmacol 10(3):322–330
Park-Min KH, Ji JD, Antoniv T et al (2009) IL-10 suppresses calcium-mediated costimulation of receptor activator NF-kappa B signaling during human osteoclast differentiation by inhibiting TREM-2 expression. J Immunol 183(4):2444–2455
Pellegatti P, Falzoni S, Donvito G et al (2011) P2X7 receptor drives osteoclast fusion by increasing the extracellular adenosine concentration. FASEB J 25(4):1264–1274
Perez-Aso M, Mediero A, Low YC et al (2016) Adenosine A2A receptor plays an important role in radiation-induced dermal injury. FASEB J 30(1):457–465
Ponte AL, Marais E, Gallay N et al (2007) The in vitro migration capacity of human bone marrow mesenchymal stem cells: comparison of chemokine and growth factor chemotactic activities. Stem Cells 25(7):1737–1745
Raisz LG (1999) Physiology and pathophysiology of bone remodeling. Clin Chem 45(8 Pt 2):1353–1358
Rath-Wolfson L, Bar-Yehuda S, Madi L (2006) IB-MECA, an A3 adenosine receptor agonist prevents bone resorption in rats with adjuvant induced arthritis. Clin Exp Rheumatol 24(4):400–406
Sauer AV, Mrak E, Hernandez RJ et al (2009) ADA-deficient SCID is associated with a specific microenvironment and bone phenotype characterized by RANKL/OPG imbalance and osteoblast insufficiency. Blood 114(15):3216–3226
Sheth S, Brito R, Mukherjea D et al (2014) Adenosine receptors: expression, function and regulation. Int J Mol Sci 15(2):2024–2052
Sophia Fox AJ, Bedi A, Rodeo SA (2009) The basic science of articular cartilage: structure, composition, and function. Sports Health 1(6):461–468
Strazzulla LC, Cronstein BN (2016) Regulation of bone and cartilage by adenosine signaling. Purinergic Signal 12(4):583–593
Takedachi M, Oohara H, Smith BJ et al (2012) CD73-generated adenosine promotes osteoblast differentiation. J Cell Physiol 227(6):2622–2631
Teitelbaum SL, Ross FP (2003) Genetic regulation of osteoclast development and function. Nat Rev Genet 4(8):638–649
Tesch AM, MacDonald MH, Kollias-Baker C et al (2002) Chondrocytes respond to adenosine via A(2)receptors and activity is potentiated by an adenosine deaminase inhibitor and a phosphodiesterase inhibitor. Osteoarthr Cartil 10(1):34–43
Tesch AM, MacDonald MH, Kollias-Baker C et al (2004) Endogenously produced adenosine regulates articular cartilage matrix homeostasis: enzymatic depletion of adenosine stimulates matrix degradation. Osteoarthr Cartil 12(5):349–359
Uccelli A, Moretta L, Pistoia V (2008) Mesenchymal stem cells in health and disease. Nat Rev Immunol 8(9):726–736
Varani K, De Mattei M, Vincenzi F et al (2008a) Characterization of adenosine receptors in bovine chondrocytes and fibroblast-like synoviocytes exposed to low frequency low energy pulsed electromagnetic fields. Osteoarthr Cartil 16(3):292–304
Varani K, De Mattei M, Vincenzi F et al (2008b) Pharmacological characterization of P2X1 and P2X3 purinergic receptors in bovine chondrocytes. Osteoarthr Cartil 16(11):1421–1429
Velasquez S, Eugenin EA (2014) Role of Pannexin-1 hemichannels and purinergic receptors in the pathogenesis of human diseases. Front Physiol 5:96
Vincenzi F, Targa M, Corciulo C et al (2013) Pulsed electromagnetic fields increased the anti-inflammatory effect of A(2)A and A(3) adenosine receptors in human T/C-28a2 chondrocytes and hFOB 1.19 osteoblasts. PLoS One 8(5):e65561
Xiong L, Jung JU, Guo HH et al (2017) Osteoblastic Lrp4 promotes osteoclastogenesis by regulating ATP release and adenosine-A2AR signaling. J Cell Biol 216(3):761–778
Young JD, Yao SY, Baldwin JM et al (2013) The human concentrative and equilibrative nucleoside transporter families, SLC28 and SLC29. Mol Asp Med 34(2–3):529–547
Yu S, Sharma R, Nie D et al (2013) ADAR1 ablation decreases bone mass by impairing osteoblast function in mice. Gene 513(1):101–110
Author information
Authors and Affiliations
Corresponding author
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 2018 Springer Nature Switzerland AG
About this chapter
Cite this chapter
Corciulo, C., Irrera, N., Cronstein, B.N. (2018). Adenosine Receptors Regulate Bone Remodeling and Cartilage Physiology. In: Borea, P., Varani, K., Gessi, S., Merighi, S., Vincenzi, F. (eds) The Adenosine Receptors. The Receptors, vol 34. Humana Press, Cham. https://doi.org/10.1007/978-3-319-90808-3_21
Download citation
DOI: https://doi.org/10.1007/978-3-319-90808-3_21
Published:
Publisher Name: Humana Press, Cham
Print ISBN: 978-3-319-90807-6
Online ISBN: 978-3-319-90808-3
eBook Packages: Biomedical and Life SciencesBiomedical and Life Sciences (R0)